2017
DOI: 10.1002/jsfa.8399
|View full text |Cite
|
Sign up to set email alerts
|

4,4′‐Dichlorodiphenyltrichloroethane (DDT) and 4,4′‐dichlorodiphenyldichloroethylene (DDE) inhibit myogenesis in C2C12 myoblasts

Abstract: These results may have significant implications for understanding the effects of developmental exposure of DDT and DDE on myogenesis and development of obesity and type 2 diabetes later in life. © 2017 Society of Chemical Industry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Currently, numerous RyR1 congenital myopathies, that typically confer a gain-of-function, have been identified (Lawal et al, 2018;Witherspoon and Meilleur, 2016), and they are well known to cause clinical neuromuscular issues. DDx has also been shown to impair myogenesis doseand time-dependently (Kim et al, 2017), and this in combination with its ability to modulate RyR1 activity to cause Ca 2þ dysregulation in muscle cells can lead to exacerbation of muscle impairments in not only populations with RyR1 congenital myopathies, but also in healthy individuals. Therefore, further studies are warranted to investigate how DDx differentially affects both population of individuals.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, numerous RyR1 congenital myopathies, that typically confer a gain-of-function, have been identified (Lawal et al, 2018;Witherspoon and Meilleur, 2016), and they are well known to cause clinical neuromuscular issues. DDx has also been shown to impair myogenesis doseand time-dependently (Kim et al, 2017), and this in combination with its ability to modulate RyR1 activity to cause Ca 2þ dysregulation in muscle cells can lead to exacerbation of muscle impairments in not only populations with RyR1 congenital myopathies, but also in healthy individuals. Therefore, further studies are warranted to investigate how DDx differentially affects both population of individuals.…”
Section: Discussionmentioning
confidence: 99%